XML 33 R32.htm IDEA: XBRL DOCUMENT v2.4.1.9
Discontinued Operations (Details 2) (USD $)
In Millions, unless otherwise specified
3 Months Ended 0 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Feb. 27, 2015
Feb. 10, 2015
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net sales $ 256us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue $ 489us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue    
Pretax income 25us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax 82us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax    
Income Tax Expense (Benefit) (1)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation (69)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation    
Net income 26abt_IncomeFromDiscontinuedOperations 151abt_IncomeFromDiscontinuedOperations    
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
Pretax Gain 2,821us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax      
Tax Expenses 1,100us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation      
After Tax Gain 1,737us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax      
Developed markets branded generics pharmaceuticals business        
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
After Tax Gain     1,600us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsBrandedGenericsPharmaceuticalsBusinessMember
 
Developed markets generics pharmaceuticals and animal health business        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Net sales 256us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
489us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
   
Pretax income 25us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
82us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
   
Income Tax Expense (Benefit) 12us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
(33)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
   
Net income 13abt_IncomeFromDiscontinuedOperations
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
115abt_IncomeFromDiscontinuedOperations
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
   
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
Pretax Gain 2,821us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
     
Tax Expenses 1,084us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
     
After Tax Gain 1,737us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_DevelopedMarketsGenericsPharmaceuticalsAndAnimalHealthBusinessMember
     
Animal Health Business        
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax [Abstract]        
After Tax Gain       131us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
/ us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis
= abt_AnimalHealthBusinessMember
AbbVie        
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]        
Income Tax Expense (Benefit) (13)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
(36)us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
   
Net income $ 13abt_IncomeFromDiscontinuedOperations
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
$ 36abt_IncomeFromDiscontinuedOperations
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember